General Cannabis (CANN) Gross Profit Margin starting from the third quarter 2024 to third quarter 2023, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


General Cannabis Corp  (NONE: CANN)


General Cannabis's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CANN Gross Profit Margin (Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
(Dec 31 2023)
Q4
(Sep 30 2023)
Q3
Y / Y Revenue Change -19.49 %
Seq. Revenue Change -10.27 %
Revenue In Millions $3.31
Gross Profit Margin 40.87 %
Gross Profit Margin Total Ranking # 2214
Gross Profit In Millions $1.35
Y / Y Gross Profit Change -18.95 %
Seq. Gross Profit Change -32.42 %


Commenting Third Quarter 2024 Gross Profit Margin
General Cannabis Corp experienced contraction in Gross Profit by -32.42 % to $3 millions and Revenue by -10.27 %, while Gross Profit Margin fell to 40.87 %, above company*s average Gross Profit Margin.


Observing third quarter 2024 results within Pharmacy Services & Retail Drugstore industry 6 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1686 to 2214.
Learn about Gross Margin
CANN's Gross Profit Margin third quarter 2024 Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 7
Retail Sector # 73
Overall # 2184

Gross Profit Margin Statistics
High Average Low
96.03 % 40.22 % 1.72 %
(Jun 30 2018)  




Other Gross Profit Margin Profitability Ratios
CANN's Cumulative Gross Profit Margin
Pharmacy Services & Retail Drugstore Industry Gross Profit Margin Trends and Statistics
Retail Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CANN's Gross Profit Margin Profitability versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CANN's Competitors
Gross Profit Margin Profit Margin for General Cannabis's Suppliers
Gross Profit Margin Profit Margin for CANN's Customers

You may also want to know
CANN's Annual Growth Rates CANN's Profitability Ratios CANN's Asset Turnover Ratio CANN's Dividend Growth
CANN's Roe CANN's Valuation Ratios CANN's Financial Strength Ratios CANN's Gross Profit Growth
CANN's Roa CANN's Inventory Turnover Ratio CANN's Growth Rates CANN's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2024, within Pharmacy Services & Retail Drugstore Industry Gross Profit MarginSep 30 2024 MRQ Gross ProfitSep 30 2024 MRQ Revenue
Herbalife Ltd   78.38 %$ 971.600  Millions$ 1,239.600  Millions
Nu Skin Enterprises Inc   70.20 %$ 301.463  Millions$ 429.463  Millions
Sharing Services Global Corporation  70.06 %$ 1.461  Millions$ 2.085  Millions
Stemtech Corporation  63.14 %$ 0.651  Millions$ 1.032  Millions
Aixin Life International Inc   62.01 %$ 0.581  Millions$ 0.936  Millions
Hwh International Inc   46.27 %$ 0.160  Millions$ 0.346  Millions
General Cannabis Corp  40.87 %$ 1.353  Millions$ 3.310  Millions
Petmed Express Inc   29.19 %$ 17.311  Millions$ 59.311  Millions
Guardian Pharmacy Services Inc   19.36 %$ 60.878  Millions$ 314.393  Millions
Walgreens Boots Alliance Inc   16.65 %$ 6,252.000  Millions$ 37,545.000  Millions
Cvs Health Corporation  13.16 %$ 12,558.000  Millions$ 95,428.000  Millions
Cosmos Health Inc   9.72 %$ 1.207  Millions$ 12.411  Millions
Wellgistics Health Inc   9.19 %$ 0.521  Millions$ 5.674  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.